Market Overview:
The global autism treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as the increasing prevalence of autism, rising awareness about autism treatments, and growing demand for better and innovative therapies. The global autism treatment market is segmented on the basis of type into serotonin uptake inhibitors (SSRIs), insomnia drugs, anticonvulsants, antipsychotics, and other therapies. The SSRI segment is expected to account for the largest share of the global autism treatment market in 2018 owing to its high efficacy in treating autistic symptoms. On the basis of application, the hospital pharmacies segment is expected to account for a major share of the global autism treatment market in 2018 followed by retail pharmacies and online pharmacies segments respectively.
Product Definition:
There is no single autism treatment that will work for everyone. However, many treatments and therapies can be effective in improving the lives of people with autism spectrum disorder (ASD). Autism treatments are important because they can help improve communication skills, social interactions, and behavior.
Serotonin uptake inhibitors (SSRIs):
SSRIs are a class of antidepressants used to treat depression. They work by increasing the amount of serotonin in the brain, which is believed to be responsible for mood elevation. SSRIs are prescribed for major depressive disorders and other unipolar disorders characterized by low levels of serotonin in the brain.
The global SSRI's market was valued at over USD 12 billion in 2015.
Insomnia drugs:
Insomnia drugs and it's usage in the treatment of autism spectrum disorder (ASD) is a clinical condition, characterized by difficulty in initiating or maintaining sleep, often associated with abnormal behaviors. The prevalence of this disorder is high and its incidence increases with age. According to the CDC, 50 million Americans are affected by some form of insomnia each year; 20 million adults (40%) have more than five symptoms from which insomnia alone causes approximately 75% cases of poor quality sleep.
Application Insights:
Based on application, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others. The online pharmacy segment is expected to witness significant growth over the forecast period owing to various advantages offered such as convenience and accessibility of medicines. Moreover, growing awareness regarding autism among parents and availability of a variety of treatments through online channels are anticipated to further propel demand for these drugs in near future.
The hospital pharmacy segment held the largest share in 2017 due to presence of key players with extensive distribution channels across major markets worldwide. Furthermore, hospitals are considered as one of the most important points from which medicines get distributed hence this channel also holds considerable share in overall revenue generation for this market owing to its high penetration rate globally compared with other applications.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high awareness levels regarding autism treatment, and availability of a wide range of effective drugs are some factors attributing to its large share. Moreover, increasing government initiatives for raising awareness about early diagnosis and proper management is expected to fuel regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to growing disposable income coupled with rising prevalence of mental disorders in developing countries such as India and China. Furthermore, improving healthcare facilities due to increased investments by governments & private players will also boost regional growth over the next eight years.
Growth Factors:
- Increasing awareness about autism and its early diagnosis
- Rising number of autism cases globally
- Growing government initiatives and funding for autism treatment research and therapies
- Technological advancements in the field of autism treatment therapies
- Increasing demand for integrated care approach for autistic children
Scope Of The Report
Report Attributes
Report Details
Report Title
Autism Treatment Market Research Report
By Type
Serotonin uptake inhibitors (SSRIs), Insomnia drugs, Anticonvulsants, Antipsychotics, Other
By Application
Hospital Pharmacies, Retail pharmacies, Online pharmacies, Others
By Companies
Pfizer, Novartis, Allergan, Merck, Eli Lilly and Company, F. Hoffmann-La Roche, Teva Pharmaceutical Industries, Johnson & Johnson Services, Bristol -Myer Squibb, Otsuka Holdings, Par Sterile Products, Janssen Pharmaceuticals, Actavis, Curemark, Mylan Pharmaceuticals, Asuragen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Autism Treatment Market Report Segments:
The global Autism Treatment market is segmented on the basis of:
Types
Serotonin uptake inhibitors (SSRIs), Insomnia drugs, Anticonvulsants, Antipsychotics, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail pharmacies, Online pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Novartis
- Allergan
- Merck
- Eli Lilly and Company
- F. Hoffmann-La Roche
- Teva Pharmaceutical Industries
- Johnson & Johnson Services
- Bristol -Myer Squibb
- Otsuka Holdings
- Par Sterile Products
- Janssen Pharmaceuticals
- Actavis
- Curemark
- Mylan Pharmaceuticals
- Asuragen
Highlights of The Autism Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Serotonin uptake inhibitors (SSRIs)
- Insomnia drugs
- Anticonvulsants
- Antipsychotics
- Other
- By Application:
- Hospital Pharmacies
- Retail pharmacies
- Online pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autism Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best autism treatment will vary depending on the individual's specific needs. However, some common treatments for autism include behavioral therapy, speech therapy, occupational therapy, and physical therapy.
Some of the major players in the autism treatment market are Pfizer, Novartis, Allergan, Merck, Eli Lilly and Company, F. Hoffmann-La Roche, Teva Pharmaceutical Industries, Johnson & Johnson Services, Bristol -Myer Squibb, Otsuka Holdings, Par Sterile Products, Janssen Pharmaceuticals, Actavis, Curemark, Mylan Pharmaceuticals, Asuragen.
The autism treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autism Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autism Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autism Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autism Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autism Treatment Market Size & Forecast, 2018-2028
4.5.1 Autism Treatment Market Size and Y-o-Y Growth
4.5.2 Autism Treatment Market Absolute $ Opportunity
Chapter 5 Global Autism Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Autism Treatment Market Size Forecast by Type
5.2.1 Serotonin uptake inhibitors (SSRIs)
5.2.2 Insomnia drugs
5.2.3 Anticonvulsants
5.2.4 Antipsychotics
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Autism Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Autism Treatment Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail pharmacies
6.2.3 Online pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autism Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autism Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Autism Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Autism Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Autism Treatment Market Size Forecast by Type
9.6.1 Serotonin uptake inhibitors (SSRIs)
9.6.2 Insomnia drugs
9.6.3 Anticonvulsants
9.6.4 Antipsychotics
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Autism Treatment Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail pharmacies
9.10.3 Online pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Autism Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Autism Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Autism Treatment Market Size Forecast by Type
10.6.1 Serotonin uptake inhibitors (SSRIs)
10.6.2 Insomnia drugs
10.6.3 Anticonvulsants
10.6.4 Antipsychotics
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Autism Treatment Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail pharmacies
10.10.3 Online pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Autism Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Autism Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Autism Treatment Market Size Forecast by Type
11.6.1 Serotonin uptake inhibitors (SSRIs)
11.6.2 Insomnia drugs
11.6.3 Anticonvulsants
11.6.4 Antipsychotics
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Autism Treatment Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail pharmacies
11.10.3 Online pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Autism Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Autism Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Autism Treatment Market Size Forecast by Type
12.6.1 Serotonin uptake inhibitors (SSRIs)
12.6.2 Insomnia drugs
12.6.3 Anticonvulsants
12.6.4 Antipsychotics
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Autism Treatment Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail pharmacies
12.10.3 Online pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Autism Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Autism Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Autism Treatment Market Size Forecast by Type
13.6.1 Serotonin uptake inhibitors (SSRIs)
13.6.2 Insomnia drugs
13.6.3 Anticonvulsants
13.6.4 Antipsychotics
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Autism Treatment Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail pharmacies
13.10.3 Online pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autism Treatment Market: Competitive Dashboard
14.2 Global Autism Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Novartis
14.3.3 Allergan
14.3.4 Merck
14.3.5 Eli Lilly and Company
14.3.6 F. Hoffmann-La Roche
14.3.7 Teva Pharmaceutical Industries
14.3.8 Johnson & Johnson Services
14.3.9 Bristol –Myer Squibb
14.3.10 Otsuka Holdings
14.3.11 Par Sterile Products
14.3.12 Janssen Pharmaceuticals
14.3.13 Actavis
14.3.14 Curemark
14.3.15 Mylan Pharmaceuticals
14.3.16 Asuragen
